Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 581026!?!581026 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=581026&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Acta+Endocrinol+(Copenh) 1978 ; 88 (3): 619-24 Nephropedia Template TP {{tp|p=581026|t=1978. Endocrine effects of lithium III Hypermagnesaemia and activation of the renin-aldosterone system |pdf=|usr=}}{{581026}} gab.com Text Endocrine effects of lithium III Hypermagnesaemia and activation of the renin-aldosterone system JO: Acta Endocrinol (Copenh) http://www.kidney.de/pget.php?&tw=1&pmid=581026 #FOAvip Hypermagnesaemia is a well-known but as yet unexplained concomitant of lithium treatment. Prior suggestions implicating a role for aldosterone in magnesium homoeostasis prompted this study of plasma renin, plasma aldosterone and serum magnesium in 17 maniodepressive patients on long-term lithium treatment. In addition to hypermagnesaemia (P less than 0.001), this group of patients had raised plasma levels of aldosterone (P less than 0.001) and increased plasma renin concentration (P less than 0.05). Serum magnesium was positively correlated to plasma aldosterone (r = 0.58, P less than 0.02). The relation between activation of the renin-aldosterone system and the presence of hypermagnesaemia during chronic lithium treatment could conceivably be mediated through a lithium-induced hypovolaemic state. Twit Text FOAVip Endocrine effects of lithium III Hypermagnesaemia and activation of the renin-aldosterone system ????Acta Endocrinol (Copenh) http://www.kidney.de/pget.php?&tw=1&pmid=581026 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=581026 #FOAvip English Wikipedia <ref>{{Cite pmid|581026}}</ref> Endocrine effects of lithium III Hypermagnesaemia and activation of the renin-aldosterone system #MMPMID581026 Transbol I; Christiansen C; Baastrup PC; Nielsen MD; Giese J Acta Endocrinol (Copenh) 1978[Jul]; 88 (3): 619-24 PMID581026show ga Hypermagnesaemia is a well-known but as yet unexplained concomitant of lithium treatment. Prior suggestions implicating a role for aldosterone in magnesium homoeostasis prompted this study of plasma renin, plasma aldosterone and serum magnesium in 17 maniodepressive patients on long-term lithium treatment. In addition to hypermagnesaemia (P less than 0.001), this group of patients had raised plasma levels of aldosterone (P less than 0.001) and increased plasma renin concentration (P less than 0.05). Serum magnesium was positively correlated to plasma aldosterone (r = 0.58, P less than 0.02). The relation between activation of the renin-aldosterone system and the presence of hypermagnesaemia during chronic lithium treatment could conceivably be mediated through a lithium-induced hypovolaemic state. |Adult[MESH] |Aged[MESH] |Aldosterone/*blood[MESH] |Bipolar Disorder/drug therapy[MESH] |Female[MESH] |Homeostasis/drug effects[MESH] |Humans[MESH] |Lithium/*adverse effects/therapeutic use[MESH] |Magnesium/*blood[MESH] |Male[MESH] |Middle Aged[MESH] |Renin/*blood[MESH]Endocrine effects of lithium III Hypermagnesaemia and activation of (epmc).pdf DeepDyve Pubget Overpricing